How doctors choose to treat their breast cancer patients may play a larger role in whether the cancer returns than experts have believed.
That’s according to a RAND Corp. study that looked at 994 women with pre-invasive breast cancer. Researchers found significant treatment variations from surgeon to surgeon that may account for up to 30 percent of cancer recurrences.
“The study found that not all surgeons are equal,” says SPH professor Beth Virnig, who co-wrote an editorial to accompany findings in the Journal of the National Cancer Institute.
Read more in Advances Magazine.
